International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal. Azerbaijan Medical Journal Gongcheng Kexue Yu Jishu/Advanced Engineering Science Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery Interventional Pulmonology

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-07-08-2021-830
Total View : 691

Abstract :

Coronavirus Disease 2019 (COVID-19) was first reported in December 2019, in the City of Wuhan, China. Within the span of a few weeks, the disease had spread to other regions of China and eventually to different parts of the world. COVID 19 has affected 221 countries and territories around the world, with a total of 111,970,286 positive cases and 2,478,354 deaths as on 22nd February 2021. Accurate disease diagnosis (for the SARS-Cov-2 virus and variants), coupled to patient isolation are currently critical strategies in restricting disease spread. Due to lack of time during this pandemic the diagnostics assays were not adequately validated. Infected individuals at times could potentially be missed by real-time reverse transcription polymerase chain reaction (rRT-PCR) for SARS-CoV-2 tests due to incorrect/inefficient sampling procedure, low limit of detection and epidemiology of the virus. rRT-PCR test results should be interpreted in conjunction with clinical examination and Computed Tomography (CT), particularly in suspected symptomatic individuals or those with epidemiological history of contact with known COVID-19 cases. Considering the above-mentioned constraints, the current scenario demands rapid and point-of-care tests for detection of SARS-CoV-2 in remote locations. To date, there is no reliable commercially available antigen detection kit. The infected subjects reveal low levels of antibodies against SARS-CoV-2 through the early period of infection. In addition, techniques such as, Digital RT-PCR technology and isothermal RNA amplification with electrochemical biosensors are some of the new technologies currently being developed to provide sensitive and specific SARS-Cov-2 antigen detection. The newly reported variant, SARS-CoV-2 VUI 202012/01 may not influence diagnostic outcomes as worldwide most PCR assays use two or more (including RdRp/ E/ N) reliable gene targets, besides S gene.

.
Full article
International Medical Journal
Journal ID : IMJ-06-08-2021-829
Total View : 2

Abstract : Current literature indicates a correlation between type 2 diabetes mellitus (T2DM), Helicobacter (H) pylori infection, and chronic inflammation. Antidiabetic therapies were involved in metabolic strategies for mitigating chronic inflammation. The current study aims to assess the impact of antidiabetic therapies on lipids and adipocytokines production in T2DM patients with H. pylori infection. The study was conducted on 127 participants allocated to 102 T2DM patients and 25 healthy subjects. The diabetic patients were subdivided into six groups according to metformin administration (mono, and dual therapy). Diabetic untreated patients showed significant (P< 0.001) elevations in the levels of body mass index, microalbuminuria, blood glucose, glycosylated hemoglobin (HbA1c), H. pylori immunoglobulin-G, and lipid profile parameters compared to healthy controls. Moreover, C-reactive protein (CRP) and leptin concentrations exhibited a significant (P< 0.001) increase, while adiponectin levels observed a marked (P< 0.001) decrease in diabetic patients compared to healthy controls. Treatment with antidiabetic therapy showed a significant (P< 0.05) amelioration in the levels of blood glucose, HbA1c%, cholesterol, low-density lipoproteins (LDL), cardio-risk factors, CRP, leptin, and adiponectin compared to diabetic-untreated patients. Notably, H. pylori infection revealed noticeable positive correlations with HbA1c%, CRP, triglycerides, and leptin/adiponectin ratio in all treated-diabetic groups. The study reveals the synergistic impact of T2DM with H. pylori infection in the increased inflammatory condition and diabetic complication. The marked amelioration in the glycemic state after treatment with antidiabetic therapies was associated with improvement in lipids, CRP, and adipocytokine levels among diabetic-treated patients with H. pylori infection..
Full article
International Medical Journal
Journal ID : IMJ-05-08-2021-827
Total View : 352

Abstract : As of June 26, 2021, there were 181 million patients with coronavirus 2019 (COVID-19) worldwide, of whom more than 3.9 million had died (https://coronavirus-monitor.info). Currently, there is an increase in the incidence of coronavirus infection in Kazakhstan in almost all regions due to a new highly contagious variant of COVID-19, Delta. According to statistics as of June 26, 2021, 414,712 Kazakhstani people fell ill, of whom 4,281 died (https://coronavirus-monitor.info/country/kazakhstan/)..
Full article
International Medical Journal
Journal ID : IMJ-29-03-2021-816
Total View : 361

Abstract : The hopes to contain the COVID-19 pandemic, which has been affecting the world for a year, have increased with the development of vaccines. However, wide coverage is needed to successfully control the disease. This study used the theory of planned behaviour to assess the intention and the factors influencing getting COVID-19 vaccine in the Kingdom of Saudi Arabia. Data were collected using an online questionnaire. The results revealed that half the study participants (51.5%) intended to vaccinate. However, a positive attitude (72%) and high perceived behavioural control (86.9%) were noted among the study participants. The theory of planned behaviour successfully predicted the participants’ intention to vaccinate. Nevertheless, perceived behavioural control was found to be a negative predictor. This study recommends normalizing the vaccine and maintaining educational campaigns to improve attitudes and consequently intention and behaviour..
Full article
International Medical Journal
Journal ID : IMJ-23-03-2021-805
Total View : 407

Abstract :

This study determined cardiac sizes, with the aid of chest radiographs, using the mean values of the CTR among adult Ijaws in Nigeria. Chest radiographs of 200 adult Ijaws were obtained and placed on a radiological illuminator box to reflect proper views of the radiographs, as cardiac and thoracic diameter values were collected. Data were analysed using SPSS for total number determination, mean, range, standard deviation and t-test value. The results recorded as follows; mean cardiac diameter for males is 13.44±1.10cm; that for female is 12.52±1.20cm and 12.98±1.19cm was recorded for both gender. For mean thoracic diameter, male value is 29.76 ± 1.85cm, that of female is 26.77±1.84cm and 28.26±2.37cm was recorded for both gender. Also the mean CTR (cardio-thoracic ratio) value was also recorded; the value for male is 45.22±3.19, that for female is 46.88±3.87 and 46.05±3.63 was recorded for both gender. Statistical analysis using student t-test showed that male adult Ijaws had higher value (p<0.05) in almost all the parameters except in CTR value, whereas females have higher CTR value (p<0.05). Findings of the index study (46.05 CTR values) provides a reference point for future studies on other Nigerian ethnic groups, which will in turn enhance better clinical interpretations necessary for diagnosing cardiovascular disorders.

.
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//